Incidence of bacterial respiratory infection and pneumonia in people with HIV with and without airflow limitation

被引:1
|
作者
Heidari, Safura-Luise [1 ]
Hove-Skovsgaard, Malene [1 ]
Arentoft, Nicoline Stender [1 ]
Svartstein, Anne-Sophie W. [1 ]
Moller, Dina Leth [1 ]
Jensen, Christian Salgard [2 ]
Benfield, Thomas [3 ]
Jensen, Jens-Ulrik Stoehr [4 ,5 ]
Thudium, Rebekka Faber [1 ]
Nielsen, Susanne D. [1 ,5 ]
机构
[1] Copenhagen Univ Hosp, Rigshosp, Viro immunol Res Unit, Dept Infect Dis, Copenhagen, Denmark
[2] Copenhagen Univ Hosp, Dept Clin Microbiol, Rigshosp, Copenhagen, Denmark
[3] Copenhagen Univ Hosp Amager & Hvidovre, Ctr Res & Disrupt Infect Dis, Copenhagen, Denmark
[4] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Dept Med, Sect Resp Med, Copenhagen, Denmark
[5] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark
关键词
HIV; Pneumonia; Airflow limitation; Smoking; Streptococcus pneumoniae; Spirometry; COMMUNITY-ACQUIRED PNEUMONIA; HOSPITALIZATION;
D O I
10.1016/j.ijid.2023.12.009
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: We aimed to determine the incidence rate, pathogen composition, and risk factors, particularly airflow limitation, associated with bacterial respiratory infection and pneumonia in a prospective cohort of well-treated people with HIV (PWH) between 2015-2021. Methods: We included 1007 PWH from the Copenhagen Comorbidity in HIV infection (COCOMO) study. Spirometry was performed at inclusion. Microbiology samples were collected prospectively. Cumulative incidence was determined by the Aalen-Johansen estimator. Cox proportional hazard models were used to calculate risk factors, adjusted for traditional and HIV-specific variables. Results: The incidence rates of first bacterial respiratory infection and pneumonia were 12.4 (95% CI 9.7-15.5) and 5.5 (95% CI: 3.8-7.7) per 10 0 0 person-years, respectively. The cumulative incidence of pneumonia was four times higher in PWH with airflow limitation (11.8% vs 3.2%, P < 0.001). Risk factors for bacterial respiratory infection were airflow limitation (hazard ratio [HR] 2.9, [95% CI: 1.7-5.1], P < 0.001), smoking (HR 2.3, [95% CI: 1.4-3.8], P < 0.001), and previous AIDS-defining event (HR 2.0, [95% CI: 1.2-3.3], P = 0.009). For pneumonia, airflow limitation (HR 2.7, [95% CI: 1.2-6.3], P = 0.016), smoking (HR 2.5, [95% CI: 1.2-5.4], P = 0.016), and older age (HR 1.5, [95% CI: 1.1-2.1], P = 0.015) were identified as risk factors. Conclusions: Increased emphasis on airflow limitation prevention, including smoking cessation, may reduce the burden of bacterial respiratory infection and pneumonia in PWH. (c) 2024 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )
引用
收藏
页码:183 / 191
页数:9
相关论文
共 50 条
  • [1] Incidence of bacterial respiratory infection and pneumonia in people with HIV with and without airflow limitation
    Heidari, S. -L.
    Hove-Skovsgaard, M.
    Arentoft, N. S.
    Svartstein, A. -S. W.
    Moller, D. L.
    Jensen, C. S.
    Benfield, T.
    Jensen, J. -U. S.
    Thudium, R. F.
    Nielsen, S. D.
    HIV MEDICINE, 2023, 24 : 241 - 243
  • [2] Airflow Limitation and Radiographic Evidence for Emphysema in People with HIV
    Harrington, K.
    Staitieh, B. S.
    Colasanti, J. A.
    Nguyen, M. L.
    Prevot, J.
    Aneja, A.
    Desai, K.
    Marconi, V. C.
    Auld, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [3] Decreasing Incidence and Determinants of Bacterial Pneumonia in People With HIV: The Swiss HIV Cohort Study
    Balakrishna, Suraj
    Wolfensberger, Aline
    Kachalov, Viacheslav
    Roth, Jan A.
    Kusejko, Katharina
    Scherrer, Alexandra U.
    Furrer, Hansjakob
    Hauser, Christoph
    Calmy, Alexandra
    Cavassini, Matthias
    Schmid, Patrick
    Bernasconi, Enos
    Battegay, Manuel
    Guenthard, Huldrych F.
    Kouyos, Roger D.
    JOURNAL OF INFECTIOUS DISEASES, 2022, 225 (09): : 1592 - 1600
  • [4] Respiratory symptoms and chronic bronchitis in people with and without HIV infection
    Sabin, C. A.
    Kunisaki, K. M.
    Bagkeris, E.
    Post, F. A.
    Sachikonye, M.
    Boffito, M.
    Anderson, J.
    Mallon, P. W. G.
    Williams, I
    Vera, J. H.
    Johnson, M.
    Babalis, D.
    Winston, A.
    HIV MEDICINE, 2021, 22 (01) : 11 - 21
  • [5] Airflow limitation in people living with HIV and matched uninfected controls
    Ronit, Andreas
    Lundgren, Jens
    Afzal, Shoaib
    Benfield, Thomas
    Roen, Ashley
    Mocroft, Amanda
    Gerstoft, Jan
    Nordestgaard, Borge G.
    Vestbo, Jorgen
    Nielsen, Susanne D.
    THORAX, 2018, 73 (05) : 431 - 438
  • [6] Decreasing incidence and determinants of bacterial pneumonia in people living with HIV: the Swiss HIV cohort study
    Balakrishna, S.
    Wolfensberger, A.
    Kachalov, V.
    Roth, J. A.
    Kusejko, K.
    Scherrer, A. U.
    Furrer, H.
    Hauser, C.
    Calmy, A.
    Cavassini, M.
    Schmid, P.
    Bernasconi, E.
    Battegay, M.
    Gunthard, H. F.
    Kouyos, R. D.
    HIV MEDICINE, 2021, 22 : 8 - 8
  • [7] Effect of HAART on the incidence of bacterial pneumonia in patients with advanced HIV infection.
    Sullivan, JH
    Moore, RD
    Keruly, JC
    Chaisson, RE
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A501 - A501
  • [8] Effect of antiretroviral therapy on the incidence of bacterial pneumonia in patients with advanced HIV infection
    Sullivan, JH
    Moore, RD
    Keruly, JC
    Chaisson, RE
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 162 (01) : 64 - 67
  • [9] Treating bacterial pneumonia in people living with HIV
    Zifodya, Jerry S.
    Crothers, Kristina
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2019, 13 (08) : 771 - 786
  • [10] Airflow limitation during respiratory syncytial virus lower respiratory tract infection predicts recurrent wheezing
    Bont, L
    Van Aalderen, WMC
    Versteegh, J
    Brus, F
    Draaisma, JTM
    Pekelharing-Berghuis, M
    Van Diemen-Steenvoorde, RAAM
    Kimpen, JLL
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2001, 20 (03) : 277 - 282